logo-large
  • Browse Categories

Publications by authors named "Imke Remer"

Claim this Profile
T
The oral spleen tyrosine kinase inhibitor fostamatinib attenuates inflammation and atherogenesis in low-density lipoprotein receptor-deficient mice.
Ingo Hilgendorf, Sara Eisele, Imke Remer, Jochen Schmitz, Katharina Zeschky

Arterioscler Thromb Vasc Biolยท September 2011


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
© PubHawk
  • About PubHawk
  • Privacy Policy
  • Sitemap
Socials: